MedTrace Logo

Immune-modulation Effects of an Arginine Rich Nutritional Supplement in Surgical Patients

NCT01885728 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2016-11-07

No results posted yet for this study

Summary

The primary objective of this study is to characterize the immune-modulatory effects of arginine-rich nutritional supplements in patients undergoing surgery. Numerical and functional changes of all circulating immune cells will be assessed with mass cytometry.

Conditions

  • Immunity

Interventions

DIETARY_SUPPLEMENT

An arginine rich nutritional supplement

Impact is a nutritional supplement formulated with 18 grams of protein per serving and 24 essential nutrients including arginine.

Sponsors & Collaborators

  • Martin Angst

    lead OTHER

Principal Investigators

  • Martin S Angst, MD · Stanford University SOM

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01885728 on ClinicalTrials.gov